CD8A and neoplasm: Although various pre-clinical and clinical studies have shown an increased number of HPV-specific CD4+ and CD8+ T cells after immunization, with proportional cytokine secretion, the activity of tumor-therapeutic vaccines against established tumors is limited [65,66,67,68,69].